Orphan designation: Recombinant chimeric monoclonal antibody against CD20, Treatment of chronic lymphocytic leukaemia

2019 ◽  
Author(s):  
Keyword(s):  
Monoclonal Antibody ◽  
Chronic Lymphocytic Leukaemia ◽  
Lymphocytic Leukaemia ◽  
Orphan Designation ◽  
Chimeric Monoclonal Antibody

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcγRIIIA/CD16

2008 ◽  
Vol 140 (6) ◽  
pp. 635-643 ◽  
Author(s):  
Christophe de Romeuf ◽  
Charles-Antoine Dutertre ◽  
Magali Le Garff-Tavernier ◽  
Nathalie Fournier ◽  
Christine Gaucher ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Chronic Lymphocytic Leukaemia ◽  
Lymphocytic Leukaemia ◽  
Anti Cd20

scholarly journals Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia

2006 ◽  
Vol 135 (4) ◽  
pp. 475-485 ◽  
Author(s):  
Mohammad Reza Rezvany ◽  
Mahmood Jeddi Tehrani ◽  
Claes Karlsson ◽  
Jeanette Lundin ◽  
Hodjattallah Rabbani ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
T Cell ◽  
Chronic Lymphocytic Leukaemia ◽  
B Cell ◽  
Lymphocytic Leukaemia ◽  
T Cell Repertoire ◽  
Cell Repertoire ◽  
Cell Chronic Lymphocytic Leukaemia
Sign in / Sign up

Export Citation Format

Share Document